Karsten Krey, a researcher in the group of Prof Andreas Pichlmair, will present this study, supported by technical data.
Beta-blockers could potentially be used to treat COVID-19, according to a new international study by Italian and Australian scientists.
In the condition known as cavernoma, lesions arise in a cluster of blood vessels in the brain, spinal cord or retina. Researchers from Uppsala University can...
In Alzheimer's disease, a protein (peptide) forms clumps in the brain and causes sufferers to lose their memory. In a recently published article, a research group...
Long-term exposure to air pollution generated by human activity is linked to about 27 per cent of COVID-19-related deaths in East Asia and 15 per cent...
A new study published by the British Journal of General Practice has found that patients' abilities to see their preferred GP has fallen greater in English...
The Science and Technology Award recognizes an individual or team in private industry who played a key role in the commercialization of proteomics technology, product,...
One of the hallmarks of Alzheimer's disease is the formation of amyloid plaques--sticky clumps of a protein called amyloid beta--that collect between neurons in...
University of Pittsburgh School of Medicine scientists have discovered the fastest way to identify potent, neutralizing human monoclonal antibodies against SARS-CoV-2,...
The technique uses microfluidics -- the submillimeter control of fluids within a precise, geometric structure. On what is basically a tricked-out microscope slide,...